A feasibility study in GBM patients showed that PET and NIRF dual-modality imaging with 68 Ga-800CW-BBN targeted imaging via the gastrin-releasing peptide receptor (GRPR) achieved pre- and intraoperative imaging with excellent correlation. This evidence concerns the gene GRPR and glioblastoma.